ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $131,974,000 | +40.9% | 2,848,567 | -25.9% | 0.90% | +49.5% |
| Q1 2019 | $93,675,000 | +30.4% | 3,842,289 | -23.8% | 0.60% | +2.0% |
| Q4 2018 | $71,844,000 | -16.4% | 5,041,696 | -10.9% | 0.59% | +3.9% |
| Q3 2018 | $85,974,000 | -9.4% | 5,656,196 | 0.0% | 0.57% | -20.6% |
| Q2 2018 | $94,911,000 | +2.8% | 5,656,196 | 0.0% | 0.71% | -8.8% |
| Q1 2018 | $92,309,000 | +27.5% | 5,656,196 | 0.0% | 0.78% | +24.5% |
| Q4 2017 | $72,399,000 | +12.9% | 5,656,196 | +8.5% | 0.63% | +20.8% |
| Q3 2017 | $64,126,000 | +383.1% | 5,213,528 | +228.7% | 0.52% | +348.3% |
| Q2 2017 | $13,274,000 | -6.4% | 1,585,913 | 0.0% | 0.12% | 0.0% |
| Q1 2017 | $14,178,000 | -37.6% | 1,585,913 | -38.7% | 0.12% | -48.0% |
| Q4 2016 | $22,730,000 | +1.7% | 2,585,913 | -21.9% | 0.22% | +9.9% |
| Q3 2016 | $22,347,000 | +45.6% | 3,310,666 | -23.2% | 0.20% | +26.1% |
| Q2 2016 | $15,346,000 | +20.7% | 4,310,666 | 0.0% | 0.16% | +20.1% |
| Q1 2016 | $12,716,000 | -30.1% | 4,310,666 | 0.0% | 0.13% | -11.3% |
| Q4 2015 | $18,191,000 | -7.5% | 4,310,666 | 0.0% | 0.15% | -17.0% |
| Q3 2015 | $19,657,000 | -50.3% | 4,310,666 | -21.4% | 0.18% | -47.6% |
| Q2 2015 | $39,529,000 | -5.2% | 5,482,505 | -3.1% | 0.35% | 0.0% |
| Q1 2015 | $41,705,000 | +514.9% | 5,658,755 | +294.7% | 0.35% | +402.9% |
| Q4 2014 | $6,782,000 | +32.5% | 1,433,797 | 0.0% | 0.07% | +7.8% |
| Q3 2014 | $5,119,000 | -21.7% | 1,433,797 | 0.0% | 0.06% | -20.0% |
| Q2 2014 | $6,538,000 | -3.0% | 1,433,797 | 0.0% | 0.08% | -7.0% |
| Q1 2014 | $6,739,000 | -10.3% | 1,433,797 | -4.4% | 0.09% | -18.9% |
| Q4 2013 | $7,515,000 | -19.5% | 1,500,000 | 0.0% | 0.11% | -20.3% |
| Q3 2013 | $9,330,000 | +37.0% | 1,500,000 | 0.0% | 0.13% | -1.5% |
| Q2 2013 | $6,810,000 | – | 1,500,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|